APPLICATION OF PHOSPHODIESTERASE TYPE 5 INHIBITORS SILDENAFIL IN PATIENTS WITH PULMONARY HYPERTENSION

APPLICATION OF PHOSPHODIESTERASE TYPE 5 INHIBITORS SILDENAFIL IN PATIENTS WITH PULMONARY HYPERTENSION

The key component of the pathogenesis of pulmonary hypertension (PH) is endothelial dysfunction with imbalance between vasodilators and vasoconstrictors and activation of the blood coagulation system. Randomized trials showed a beneficial effect of phosphodiesterase type 5 (PDE-5) inhibitors on vasc...

Full description

Bibliographic Details
Main Authors:	T. V. Martynyuk, Z. H. Dadacheva, V. M. Paramonov, O. A. Arkhipova, S. N. Nakonechnikov, I. Ye. Chazova
Format:	Article
Language:	Russian
Published:	InterMedservice 2015-06-01
Series:	Евразийский Кардиологический Журнал
Subjects:	легочная гипертензия легочная артериальная гипертензия хроническая тромбоэмболическая лёгочная гипертензия оксид азота цгмф ингибиторы фосфодиэстеразы типа 5 силденафил pulmonary hypertension pulmonary arterial hypertension nitric oxide cyclic guanosine-monophosphate pde-5 inhibitors sildenafil
Online Access:	https://www.heartj.asia/jour/article/view/5633

Similar Items

SUCCESSFUL TREATMENT OF INOPERABLE THROMBOEMBOLIC PULMONARY HYPERTENSION PATIENT WITH SILDENAFIL IN HIGH DOSES
by: Z. H. Dadacheva, et al.
Published: (2014-12-01)

ВОЗМОЖНОСТИ МЕДИКАМЕНТОЗНОГО ЛЕЧЕНИЯ ХРОНИЧЕСКОЙ ТРОМБОЭМБОЛИЧЕСКОЙ ЛЕГОЧНОЙ ГИПЕРТЕНЗИИ
by: Т. В. Мартынюк, et al.
Published: (2015-07-01)

ИННОВАЦИЯ В МЕДИКАМЕНТОЗНОМ ЛЕЧЕНИИ ПАЦИЕНТОВ С ХРОНИЧЕСКОЙ ТРОМБОЭМБОЛИЧЕСКОЙ ЛЕГОЧНОЙ ГИПЕРТЕНЗИЕЙ: СТИМУЛЯТОР РАСТВОРИМОЙ ГУАНИЛАТЦИКЛАЗЫ — РИОЦИГУАТ
Published: (2016-12-01)

CLINICAL CASE: THERAPY WITH SILDENAFIL IN THE TREATMENT OF IDIOPATHIC PULMONARY HYPERTENSION
by: Z. S. Valieva, et al.
Published: (2015-12-01)

Pharmacological test with sildenafil at pulmonary hypertension assessing in children with congenital heart diseases
by: O. S. Yanulevich, et al.
Published: (2010-10-01)

INHALED NITRIC OXIDE: CLINICAL EFFECTS AND INFLUENCE ON THE PROFILE OF INFLAMMATORY MARKERS IN PATIENTS WITH IDIOPATHIC PULMONARY HYPERTENSION
by: T. V. Martynyuk, et al.
Published: (2015-12-01)

Chronic thromboembolic pulmonary hypertension: approaches to diagnosis and treatment
by: N. A. Shostak, et al.
Published: (2013-12-01)

Путь от тромбоэмболии легочной артерии к хронической тромбоэмболической легочной гипертензии: факторы риска
by: О. Васильцева, et al.
Published: (2021-09-01)

Ингибитор фосфодиэстеразы-5 в лечении легочной артериальной гипертензии
Published: (2019-09-01)

CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION AND PROBLEMS OF RARE AND INTERDISCIPLINARY DISEASE
by: N. A. Shostak, et al.
Published: (2015-09-01)

About choosing a vasodilator for vasoreactivity tests in heart transplant candidates
by: А. Е. Баутин, et al.
Published: (2015-10-01)

PULMONAR.Y ARTERIAL HYPERTENSION ASSOCIATED WITH A SYSTEMIC SCLEROSIS: REVIEW OF LITERATURE
by: N. N. Yudkina, et al.
Published: (2015-12-01)

A case of combined treatment of severe chronic thromboembolic pulmonary hypertension
by: R. S. Akchurin, et al.
Published: (2015-12-01)

Баллонная легочная ангиопластика у пациентов с хронической тромбоэмболической легочной гипертензией: непосредственные и отдаленные результаты
by: А.Г. Бадоян, et al.
Published: (2024-11-01)

Formation of the pulmonary hypertension in patients with a liver cirrhosis
by: T. P. Kalachyova, et al.
Published: (2009-08-01)

Drug-induced pulmonary artery hypertension
by: O. D. Ostroumova, et al.
Published: (2022-05-01)

NEW OPPORTUNITIES PATHOGENETIC THERAPY OF PULMONARY ARTERIAL HYPERTENSION
by: T. V. Martynuk, et al.
Published: (2013-03-01)

Current approaches to management of patients with pulmonary hypertension
by: S. N. Avdeev
Published: (2014-12-01)

RESPIRATORY FUNCTION IN PATIENTS WITH RHEUMATIC HEART DISEASE COMPLICATED WITH PULMONARY HYPERTENSION
by: N. A. Shostak, et al.
Published: (2016-01-01)

REMODELING OF THE RIGHT HEART AND THE LEVEL OF BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: A COMPARATIVE CROSS-SECTIONAL OBSERVATIONAL STUDY
by: A. A. Klimenko, et al.
Published: (2015-09-01)

FEATURES OF PULMONARY ARTERIAL HYPERTENSION IN THE RUSSIAN REGISTER
by: O. A. Arkhipova, et al.
Published: (2014-12-01)

CLINICAL CASE: COMBINATION THERAPY WITH BOSENTAN AND SILDENAFIL IN THE TREATMENT OF IDIOPATHIC PULMONARY HYPERTENSION
by: V. V. Bystrov, et al.
Published: (2014-12-01)

Retrospective analysis of the occurrence of secondary pulmonary hypertension in patients with viral pneumonia based on ultrasound examination of the heart in patients with viral pneumonia in the context of the COVID-19 pandemic
by: E. Yu. Titova, et al.
Published: (2021-10-01)

РАЗБОР КЛИНИЧЕСКОГО СЛУЧАЯ ЛЕЧЕНИЯ ПАЦИЕНТКИ С РЕЦИДИВИРУЮЩИМИ ВЕНОЗНЫМИ ТРОМБОЭМБОЛИЧЕСКИМИ ОСЛОЖНЕНИЯМИ И ХРОНИЧЕСКОЙ ПОСТТРОМБОЭМБОЛИЧЕСКОЙ ЛЕГОЧНОЙ ГИПЕРТЕНЗИЕЙ
Published: (2014-12-01)

Ингаляционная терапия оксидом азота, полученным методом синтеза из атмосферного воздуха, в послеоперационном периоде кардиохирургических вмешательств у детей: одноцентровое ретроспективное когортное исследование
by: Андрей Евгеньевич Баутин, et al.
Published: (2021-10-01)

MACITENTAN: THE EVOLUTION OF THE CLASS ENDOTHELIN RECEPTOR ANTAGONISTS TO IMPROVE EFFICACY AND SAFETY OF PAH TREATMENT
by: T. V. Martynuk, et al.
Published: (2013-06-01)

Modern approaches to diagnostics and treatment of patients with pulmonary arterial hypertension
by: Т. Г. Волкова, et al.
Published: (2015-10-01)

THE DIAGNOSIS AND TREATMENT OF PRIMARY PULMONARY HYPERTENSION: A MODERN VIEW ON THE PROBLEM
by: N. V. Porodenko, et al.
Published: (2014-06-01)

Riociguat is a novel medication for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
by: N. A. Tsareva, et al.
Published: (2016-12-01)

Klinicheskiy sluchay: primenenie alprostadila pri lechenii bol'noy s idiopaticheskoy (pervichnoy) legochnoy gipertenziey
by: O O Matvienko, et al.
Published: (2006-06-01)

Pulmonary hypertension: current issues of diagnosis and treatment
by: T. V. Martyniuk, et al.
Published: (2011-03-01)

ОЦЕНКА РЕМОДЕЛИРОВАНИЯ ПОЛОСТЕЙ СЕРДЦА У ПАЦИЕНТОВ С ОСТРОЙ ТРОМБОЭМБОЛИЕЙ ЛЕГОЧНОЙ АРТЕРИИ МЕТОДОМ ТРАНСТОРАКАЛЬНОЙ ЭХОКАРДИОГРАФИИ
by: Н. В. Матвеева, et al.
Published: (2015-10-01)

Pulmonary hypertension associated with portal hypertension and pulmonary hypertension in sarcoididosis of breathing organs: complex pathogenetic relationships
by: T. P. Kalacheva, et al.
Published: (2018-12-01)

AMBRISENTAN: THE POSSIBILITY OF THE TREATMENT FOR PULMONARY ARTERIAL HYPERTENSION WITH THE SELECTIVE BLOCKADE OF THE ENDOTHELIN SYSTEM
by: T. V. Martynuk, et al.
Published: (2014-03-01)

PERFUSION LUNG SCINTIGRAPHY IN PATIENTS WITH A PULMONARY HYPERTENSION OF A VARIOUS ETIOLOGY
by: O. A. Arkhipova, et al.
Published: (2015-12-01)

MEDICAL TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
by: K. V. Mershin, et al.
Published: (2014-03-01)

CONTROVERSIAL ASPECTS OF DEVELOPMENT AND TREATMENT OF THE SYNDROME OF PULMONARY HYPERTENSION IN CHILDREN WITH BRONCHOPULMONARY DYSPLASIA
by: Анастасия Олеговна Затолокина, et al.
Published: (2017-02-01)

СОВРЕМЕННЫЕ ВОЗМОЖНОСТИ ОЦЕНКИ ЛЕГОЧНОЙ ГИПЕРТЕНЗИИ ПРИ ЭХОКАРДИОГРАФИИ У ПАЦИЕНТОВ С COVID-19
by: Ольга Петровна Мамаева, et al.
Published: (2022-11-01)

SURGICAL TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: MODERN TRENDS AND OWN EXPERIENCE
by: R. S. Akchurin, et al.
Published: (2016-06-01)

ASSESSMENT OF PULMONARY HYPERTENSION BY ECHOCARDIOGRAPHY IN PATIENTS WITH PREDIALYSIS STAGE OF CHRONIC KIDNEY DISEASE
by: M. P. Vasilyeva, et al.
Published: (2016-02-01)